Key Updates on Today’s Regulatory Landscape for Outreach Laboratories
Impossible d'ajouter des articles
Désolé, nous ne sommes pas en mesure d'ajouter l'article car votre panier est déjà plein.
Veuillez réessayer plus tard
Veuillez réessayer plus tard
Échec de l’élimination de la liste d'envies.
Veuillez réessayer plus tard
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
Key Updates on Today’s Regulatory Landscape for Outreach Laboratories
-
Lu par :
-
De :
À propos de ce contenu audio
In this episode of the “Leveraging the Laboratory” podcast, Jane Hermansen, outreach manager at Mayo Clinic Laboratories, welcomes Chelsea Conn, Mayo Clinic Laboratories’ director of regulatory affairs. Together, they break down the latest regulatory changes and share actionable strategies to help outreach programs stay informed and prepared. Key topics include:
- FDA rule for lab-developed tests (01:36): What the recent rescinding of the FDA rule means for labs.
- New Clinical Laboratory Improvement Act (CLIA) regulations (04:36): Clarifications on lab director qualification updates from late 2024.
- College of American Pathologists (CAP) accreditation (07:52): New checklist requirements for reporting and submitting to public health authorities.
- Protecting Access to Medicare Act (PAMA) reform (11:40): The latest developments on new approaches to reimbursement for laboratory tests.
- Recommended resources (17:32): How to stay up to date on regulations affecting the laboratory industry.
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !
Aucun commentaire pour le moment